Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,930,518
+$3,801,904 QoQ
Shares Held
140,046
+13.6% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#114
of 473 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,145,499 across 249 Biotechnology names. CYTK ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
This page
|
140,046 | $11,930,518 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,930,518 | 140,046 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,128,614 | 123,329 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $7,746,161 | 121,910 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $7,012,346 | 127,590 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,359,760 | 131,954 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $5,225,584 | 130,022 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,289,342 | 133,702 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,510,662 | 123,308 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,651,678 | 122,770 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,049,420 | 100,548 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,098,357 | 49,088 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $1,446,132 | 49,088 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $1,601,250 | 49,088 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $1,512,360 | 42,977 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $1,969,206 | 42,977 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $2,082,235 | 42,977 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $1,675,482 | 42,644 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $1,567,811 | 42,592 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $1,313,980 | 28,828 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $1,030,312 | 28,828 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $504,189 | 25,477 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $592,595 | 25,477 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $591,294 | 28,455 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $616,050 | 28,455 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $621,022 | 26,348 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $310,642 | 26,348 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||